Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
Drugmaker stocks slammed over Zantac lawsuit concerns
02:20pm, Friday, 12'th Aug 2022
Thousands of lawsuits have been filed against companies including Sanofi, GlaxoSmithKline, Haleon and Pfizer accusing them of failing to properly warn users of the recalled heartburn drugs' health ris
GSK and Sanofi Push Back on Zantac Worries. Shares Rebounded.
10:49am, Friday, 12'th Aug 2022
After a UBS analyst's note sparked a two-day plunge in the drug makers, their shares rallied Friday after they said there is no evidence the heartburn drug causes cancer. A J.P. Morgan note also calle
The Zacks Analyst Blog Highlights Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals
10:05am, Friday, 12'th Aug 2022 Zacks Investment Research
Amgen, ChemoCentryx, Mersana Therapeutics, GSK and Vertex Pharmaceuticals are part of the Zacks top Analyst Blog.
Drugmakers' shares tumble on growing investor fears over Zantac litigation
09:12am, Friday, 12'th Aug 2022
CNBC's Julianna Tatelbaum discusses U.S. litigation focused on heartburn drug Zantac.
GSK defends Zantac ahead of trials that have cratered the stock
04:49am, Friday, 12'th Aug 2022
GSK on Friday put out a statement saying there's no link between a withdrawn heartburn medication and cancer, helping to stem a slide in its stock that has wiped out billions of dollars in valuation f
GSK, Sanofi and Haleon shares stabilise after Zantac litigation slump
04:24am, Friday, 12'th Aug 2022
Shares in GSK, Sanofi
GSK to 'vigorously defend' itself against claims stomach acid drug Zantac causes cancer
04:02am, Friday, 12'th Aug 2022
GSK PLC (LSE:GSK, NYSE:GSK) and Haleon PLC (LSE:HLN, NYSE:HLN) issued separate statements today after their stock was hit by lawsuits claiming GSK's acid indigestion drug Zantac can cause cancer. �
European shares eke out gains at open as healthcare stocks rebound
03:28am, Friday, 12'th Aug 2022
European shares eked out gains on Friday at the open after Sanofi and GSK led a rebound in healthcare stocks, with the main STOXX 600 index set for weekly gains.
Why Pfizer Stock Slipped Today
09:26pm, Thursday, 11'th Aug 2022 The Motley Fool
Investors appear to have a case of heartburn over lawsuits related to Zantac.
U.S. stocks end mixed as rally tied to cooler inflation data takes breather
08:45pm, Thursday, 11'th Aug 2022 MarketWatch
Stocks finish mostly lower Thursday, despite hitting a three-month high in morning action after another batch of July data suggested U.S. inflation may be easing.
Why GSK Is So Deep in the Red Today
06:51pm, Thursday, 11'th Aug 2022 The Motley Fool
A wave of litigation is coming into view.
Biotech Stock Roundup: AMGN's Q2 Earnings, CCXI Acquisition & More Updates
03:25pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Earnings updates from Amgen (AMGN) and its ChemoCentryx (CCXI) acquisition are a few key highlights from the biotech sector during the past week.
Why GSK Is So Deep in the Red Today
02:51pm, Thursday, 11'th Aug 2022
A wave of litigation is coming into view.
GSK, PFE, SNY Stocks Fall on Zantac Litigation
11:34am, Thursday, 11'th Aug 2022
Source: Willy Barton / Shutterstock.com Investors in GSK (NYSE: GSK ) stock, Pfizer (NYSE: PFE ) and Sanofi (NASDAQ: SNY ) are all feeling the heat today. Reportedly, they're concerned about legal pos
GSK and Haleon given headache by cancer-linked heartburn drug
11:08am, Thursday, 11'th Aug 2022
GSK PLC (LSE:GSK, NYSE:GSK) and Haleon PLC (LSE:HLN, NYSE:HLN) were the biggest FTSE 100 fallers on Thursday amid investor concerns surrounding US lawsuits over heartburn drug, which was withdrawn fr
